GGrantIndex
Sort

326,823 grants matching clinical trial

High-Bandwidth Wireless Interfaces for Continuous Human Intracortical Recording

$2,020,491
Leigh R Hochberg · Massachusetts General Hospital · UH2 · FY2019 · NS

Immunopathogenesis of Acute HIV-1 Infection

$2,020,340
University Of Colorado Denver · P01 · FY2005 · AI

Human iPS/ES Cell-Based Models for Predictive Neural Toxicity and Teratogenicity

$2,020,212
James Alexander Thomson · Morgridge Institute For Research, Inc. · UH3 · FY2014 · TR

Optimizing HIV Care in Less Developed Countries

$2,020,176
Kenneth Alan Freedberg · Massachusetts General Hospital · R01 · FY2011 · AI

HIV PREVENTION TRIAL UNIT (HPTU)-PUNE, INDIA

$2,020,124
Johns Hopkins University · U01 · FY2004 · AI

MICHIGAN CANCER RESEARCH CONSORTIUM

$2,020,001
Philip J Stella · Saint Joseph Mercy Health System · UG1 · FY2015 · CA

MICHIGAN CANCER RESEARCH CONSORTIUM

$2,020,001
Philip J Stella · Saint Joseph Mercy Health System · UG1 · FY2016 · CA

Human Artificial Chromosomes for Cancer Research and Functional Genomics

$2,019,980
Vladimir Larionov · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Preserving Renal Function & Protective Immunity Via Anti-LFA1-Based CNI Avoidance

$2,019,903
Christian P Larsen · Emory University · U01 · FY2011 · AI

New Approaches to Dementia Heterogeneity

$2,019,770
Bruce L Miller · University Of California, San Francisco · P50 · FY2012 · AG

Sex-based Differences in Glioma

$2,019,654
Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · P01 · FY2022 · CA

Genetics and Biology of Pancreatic Ductal Adenocarcinoma

$2,019,635
Ronald Anthony Depinho · Dana-Farber Cancer Inst · P01 · FY2011 · CA

Investigation of the Cortical Communication (CORTICOM) System

$2,019,539
Nathan E Crone · Johns Hopkins University · UH3 · FY2024 · NS

New Approaches to Dementia Heterogeneity

$2,019,359
Bruce L Miller · University Of California, San Francisco · P50 · FY2014 · AG

Development of a Longitudinal Observational Research Registry for the Study of Medicinal Cannabis Use and Health

$2,019,346
Ryan G Vandrey · Johns Hopkins University · UM1 · FY2025 · DA

Mixed Hematopoietic Chimerism after Stem Cell Allografts

$2,019,270
Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2006 · CA

Optimization of Cannabinoids for Development as FDA-Approved Migraine Therapeutics

$2,019,222
George Pappas · Schedule 1 Therapeutics, Inc. · R44 · FY2024 · DA

Development of TNX-1300 (Double Mutant Cocaine Esterase) for the Treatment of Life-Threatening Cocaine Intoxication

$2,019,191
Gregory M Sullivan · Tonix Pharmaceuticals, Inc. · U01 · FY2023 · DA

Follow-up Study: Comparison of AMD Treatments Trial (CATT)

$2,019,123
Maureen G Maguire · University Of Pennsylvania · U10 · FY2013 · EY

Hematopoietic Chimerism after Stem Cell Allografts

$2,019,079
Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2015 · CA

NIMH COLLABORATIVE HIV/STD PREVENTION TRIAL

$2,019,024
Research Triangle Institute · U10 · FY2003 · MH

Clinical Implementation of Carrier Testing using NGS

$2,018,840
Katrina A Goddard · Kaiser Foundation Research Institute · UM1 · FY2016 · HG

Immunotherapy for Malignant Mesothelioma and Lung Cancer

$2,018,756
Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Lifespan/Tufts/brown Center for AIDS Research (CFAR)

$2,018,753
Susan Cu-Uvin · Miriam Hospital · P30 · FY2015 · AI

Production and quality analysis of clinical drug for a novel CNS protein kinase inhibitor therapeutic candidate

$2,018,653
D. Martin Watterson · Neurokine Therapeutics, Llc · R42 · FY2019 · AG